The study investigators hypothesize that SARS-Cov2 infection alters the composition ofthe digestive microbiota and its functionality, resulting in changes in intestinalpermeability and consequently in microbial digestive translocation. These changes maycorrelate with the magnitude of the SARS-CoV-2 viral load in the gastrointestinal tractand may have an impact on the clinical manifestations and evolvability of COVID-19.
Not Provided
Other: Fecal sample
Fecal sample taken to investigate intestinal microbiota
Inclusion Criteria:
- patient hospitalized at in Nimes University hospital
- Infection with SARS-CoV-2 confirmed by RT-PCR
- The patient must have signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
Exclusion Criteria:
- The subject is participating in an interventional study susceptible to modify the
intestinal microbiota, or is in a period of exclusion determined by a previous study
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient with a chronic digestive pathology or having been operated in the previous
year or having enteral nutrition or having had bariatric surgery
- Patient is pregnant, parturient or breastfeeding
CHU de Nimes
Nîmes, France
Albert Sotto, Principal Investigator
CHU Nimes